The Interplay Between Immunity, Infection, and Neurocognitive Disorders
A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Medicine".
Deadline for manuscript submissions: closed (30 June 2025) | Viewed by 735
Special Issue Editor
Special Issue Information
Dear Colleagues,
A growing body of research has outlined the interplay between immunity, infection, and neurocognitive disorders. The COVID-19 pandemic provided significant impetus in advancing our understanding of this triple connection, with exposure to pathogens beyond SARS-CoV-2 having been consistently linked to an increased risk of neurodegenerative disease and cognitive impairment. Big data and translational studies have narrowed the gap between observation and mechanism for the connections between pathogen exposure and cognitive sequelae. In this Special Issue, we will attempt to decipher the multi-modal relationships and possible causative mechanisms by which host–pathogen interactions, and their specific footprints, impact the development of cognitive impairment. Authors of original studies, both clinical and translational, case reports, as well as high-quality reviews, are welcome to submit. Beyond long COVID, studies focusing on neurocognitive disorders arising from other pathogens will also be welcome.
Dr. George D. Vavougios
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunity
- autoimmunity
- cognition
- cognitive impairment
- infection
- neurogeneration
- neuroinflammation
- computational biology
- translational studies
- meta-analysis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
